Donation

Donate
Myeloma Minute

Best Therapies for Elderly Patients
Dr. Shaji Kumar

Best Therapies for Patients Opting for Transplant
Dr.Edward Stadtmauer

Webcast from the 2014 Boca Raton Patient & Family Seminar 
February 28 - March 1, 2014

Treatment Outcomes and Prognostic Factors with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in African American (AA) Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial
Treatment Outcomes and Prognostic Factors with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in African American (AA) Patients with Newly Diagnosed Myeloma in the Determination Trial
Read more
Dr. Shaji Kumar
IMF’s Black Swan Research Initiative®: ASCENT Trial
Read more
Previous Post
BOCA PNF 2014: Myeloma101/BSRI
Next Post
BOCA PNF 2014: Management of Bone Disease/Clinical Trials and New Drugs

Give Where Most Needed

Learn More